LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹25 Cr | ₹26 Cr | ₹15 Cr | ₹12 Cr | ₹11 Cr |
What is the latest Total Current Liabilities ratio of LACTOSE (INDIA) ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹25 Cr |
Mar2023 | ₹26 Cr |
Mar2022 | ₹15 Cr |
Mar2021 | ₹12 Cr |
Mar2020 | ₹11 Cr |
How is Total Current Liabilities of LACTOSE (INDIA) Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹25 Cr | -4.04 | |
Mar2023 | ₹26 Cr | 77.51 | |
Mar2022 | ₹15 Cr | 28.26 | |
Mar2021 | ₹12 Cr | 1.93 | |
Mar2020 | ₹11 Cr | - |
Compare Total Current Liabilities of peers of LACTOSE (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LACTOSE (INDIA) | ₹266.4 Cr | 2.3% | -10.3% | 78.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,661.0 Cr | -1.8% | 2.7% | 49.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,496.0 Cr | -0.2% | -3.4% | 57% | Stock Analytics | |
CIPLA | ₹121,970.0 Cr | -0.7% | 0.6% | 22.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,877.0 Cr | -1.8% | 11.3% | 18% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,163.2 Cr | 1.9% | 0.5% | 41.9% | Stock Analytics |
LACTOSE (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LACTOSE (INDIA) | 2.3% |
-10.3% |
78.2% |
SENSEX | 0.7% |
-2% |
9.7% |
You may also like the below Video Courses